Akebia Therapeutics, Inc. (AKBA)

1.40 -0.12 (-7.89%) USD  |  NASDAQ  |  Jan 12, 16:00
1.40 0.00 (0.00%) Pre-Market: 08:24
More

Akebia Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade